| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fb7bbc09927d64558e1e99a3b7c719b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0275 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 |
| filingDate |
2018-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14f9394de99587cab007bc10bafb368f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19662cadd996d7941d5dfbd88c44293f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37834dd29dcfbe6ea3a71cab3610307e |
| publicationDate |
2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019035963-A1 |
| titleOfInvention |
NANOPARTICLE COMPOSITIONS FOR VACCINES AGAINST SALMONELLA |
| abstract |
The present invention relates to nanoparticle compositions for use as vaccines against salmonella. The invention relates to a composition comprising: an outer membrane protein (OMP) of Salmonella enteritidis or a killed whole antigenic protein (KAg) of Salmonella enteritidis; and a nanoparticle of polyanhydride or chitosan. In some embodiments, the nanoparticle further comprises a flagellar protein. The invention provides a vaccine comprising: a composition comprising an OMP protein of Salmonella enteritidis or a killed whole antigenic protein (KAg) of Salmonella enteritidis; a nanoparticle of polyanhydride or chitosan; and a pharmaceutically acceptable vector. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524061-B2 |
| priorityDate |
2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |